Skip to main content

Table 2 Levels of soluble receptor for advanced glycation end products (sRAGE) in sera and in synovial fluid of rheumatoid arthritis patients according to different disease characteristics

From: Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

Disease characteristic

n

Blood sRAGE

Synovial sRAGE

Erosive rheumatoid arthritis

39

  

   Rheumatoid factor-positive

33

832 ± 87 (771)

345 ± 39 (323)

   Rheumatoid factor-negative

6

1105 ± 209 (935)

447 ± 171 (273)

Non-erosive rheumatoid arthritis

23

  

   Rheumatoid factor-positive

5

582 ± 141 (602)

463 ± 153 (498)

   Rheumatoid factor-negative

18

945 ± 128 (772)

397 ± 79 (281)

  1. Data presented as the mean ± standard error of the mean (median).